Innovator Series Episode 4: From NIH to a Biotech

Presented by: Jolly Mazumdar, PhD, MBA, Chimeron Bio

About Episode 4

In episode 4, Jolly shares an intimate look at the ups and downs of building a company that develops novel RNA delivery platform technologies within oncology, infectious diseases and rare genetic disorders therapeutic areas.

About Jolly Mazumdar

Jolly is CEO of Chimeron Bio. Prior to Chimeron, she served in clinical development leadership roles at GlaxoSmithKline in the divisions of Immuno-oncology and Personalized Oncology. She obtained her PhD in cell biology from the University of Georgia and has an MBA from Columbia Business School.

Complete the form to the right for access to episode 4 of the Charles River Innovator's Series.


Also Available from the Charles River Innovator’s Series...


Ready to collaborate?

Connect with an Advisor